Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Cash from Financing Activities: 2020-2025

Historic Cash from Financing Activities for Incannex Healthcare (IXHL) over the last 5 years, with Jun 2025 value amounting to $21.4 million.

  • Incannex Healthcare's Cash from Financing Activities rose 129286.54% to $67.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.6 million, marking a year-over-year change of. This contributed to the annual value of $21.4 million for FY2025, which is N/A change from last year.
  • According to the latest figures from FY2025, Incannex Healthcare's Cash from Financing Activities is $21.4 million, which was up 161.72% from $8.2 million recorded in FY2023.
  • Over the past 5 years, Incannex Healthcare's Cash from Financing Activities peaked at $21.4 million during FY2025, and registered a low of $193,980 during FY2022.
  • Its 2-year average for Cash from Financing Activities is $14.8 million, with a median of $14.8 million in 2023.
  • As far as peak fluctuations go, Incannex Healthcare's Cash from Financing Activities crashed by 98.44% in 2022, and later surged by 4,114.35% in 2023.
  • Over the past 4 years, Incannex Healthcare's Cash from Financing Activities (Yearly) stood at $12.4 million in 2021, then reached $9.3 million in 2021, then slumped by 98.44% to $193,980 in 2022, then soared by 4,114.35% to $8.2 million in 2023, then reached $21.4 million in 2025.